Hepatocellular Carcinoma

FMO2⁺ cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma
Wenxin Xu, Jialei Weng, Yufei Zhao, Peiyi Xie, Minghao Xu, Shaoqing Liu, Qiang Yu, Mincheng Yu, Bugang Liang, Junbo Chen, Hui-Chuan Sun, Hui Li, Qinghai Ye, Yinghao Shen

Journal for ImmunoTherapy of Cancer May 2025, 13 (5) e011648; DOI: 10.1136/jitc-2025-011648
Letter to the editor: transfer learning radiomic model predicts intratumoral tertiary lymphoid structures in hepatocellular carcinoma: a multicenter study
Pei Chen, Xuewei Wu, Shuixing Zhang

Journal for ImmunoTherapy of Cancer Mar 2025, 13 (3) e012007; DOI: 10.1136/jitc-2025-012007
Differential regulation of calcium-NFAT signaling pathway by Akt isoforms: unraveling effector dynamics and exhaustion of cytotoxic T lymphocytes in tumor microenvironment
Wen-Ling Chen, Yong-Lin Chang, Su-Fang Lin, Ulrike Protzer, Masanori Isogawa, Hung-Chih Yang, Li-Rung Huang

Journal for ImmunoTherapy of Cancer Mar 2025, 13 (3) e009827; DOI: 10.1136/jitc-2024-009827
Letter to the editor: safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria
Bi-Cheng Wang

Journal for ImmunoTherapy of Cancer Mar 2025, 13 (3) e011909; DOI: 10.1136/jitc-2025-011909
Transfer learning radiomic model predicts intratumoral tertiary lymphoid structures in hepatocellular carcinoma: a multicenter study
Shichao Long, Mengsi Li, Juan Chen, Linhui Zhong, Ganmian Dai, Deng Pan, Wenguang Liu, Feng Yi, Yue Ruan, Bocheng Zou, Xiong Chen, Kai Fu, Wenzheng Li

Journal for ImmunoTherapy of Cancer Mar 2025, 13 (3) e011126; DOI: 10.1136/jitc-2024-011126
Targeted delivery of CCL3 reprograms macrophage antigen presentation and enhances the efficacy of immune checkpoint blockade therapy in hepatocellular carcinoma
Muqi Liu, Linzhe Li, Lu Cao, Wei Li, Xingshi Gu, Min Yang, Di Wu, Yanan Li, Yao Deng, Juan Zhang, Cejun Yang, Qi Liang, Huaping Liu, Pengfei Rong, Xiaoqian Ma, Wei Wang

Journal for ImmunoTherapy of Cancer Feb 2025, 13 (2) e010947; DOI: 10.1136/jitc-2024-010947
Phosphatidylserine as a tumor target for CAR-T cell therapy
Celia Martín-Otal, Inés Sánchez-Moreno, Alvaro Gómez-Morón, Carla Castro, Noelia Casares, Flor Navarro, Marta Gorraiz, Pedro Justicia-Lirio, Felix Pareja, María Collantes, Iván Peñuelas, Mercedes Iñarrairaegui, Bruno Sangro, Isabel Vivas, Marta Larrayoz, Juan Roberto Rodriguez, Felipe Prosper, Sandra Hervas-Stubbs, Noa Martin-Cofreces, Juan Jose Lasarte, Teresa Lozano

Journal for ImmunoTherapy of Cancer Feb 2025, 13 (2) e009468; DOI: 10.1136/jitc-2024-009468
Ethanol inhibits the growth and metastasis of hepatocellular carcinoma by inducing immunogenic cell death
Yu-Chen Hsu, Meng-Chuan Wu, Meng Tzu Weng, Ying-Te Lee, Huei-Chi Chou, Hsuan-Shu Lee, Li-Fang Wang, Jin-Chuan Sheu, Chien-Hung Chen

Journal for ImmunoTherapy of Cancer Feb 2025, 13 (2) e010472; DOI: 10.1136/jitc-2024-010472
Corticosteroid premedication on anti-tumor effect of immune checkpoint blockade in murine hepatocellular carcinoma models
Ying-Chun Shen, Nai-Wen Chang, Ching-Ping Yeh, Wan-Ying Lin, Ming-Feng Wei, Da-Liang Ou, Chia-Lang Hsu, Ann-Lii Cheng

Journal for ImmunoTherapy of Cancer Feb 2025, 13 (2) e009704; DOI: 10.1136/jitc-2024-009704
Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria
Lixing Li, Xin Xu, Wentao Wang, Peiran Huang, Lei Yu, Zhenggang Ren, Jia Fan, Jian Zhou, Lan Zhang, Zheng Wang

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e010035; DOI: 10.1136/jitc-2024-010035

Main menu

Hepatocellular Carcinoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Hepatocellular Carcinoma

Pages